المؤلفون: Vishnoi K; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA., Kumar S; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA., Ke R; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA., Rana A; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA; University of Illinois Hospital & Health Sciences System Cancer Center, The University of Illinois at Chicago, Chicago, IL 60612, USA; Jesse Brown VA Medical Center, Chicago, IL 60612, USA., Rana B; Department of Surgery, Division of Surgical Oncology, The University of Illinois at Chicago, Chicago, IL 60612, USA; University of Illinois Hospital & Health Sciences System Cancer Center, The University of Illinois at Chicago, Chicago, IL 60612, USA; Jesse Brown VA Medical Center, Chicago, IL 60612, USA. Electronic address: basrana@uic.edu.

المصدر: Current opinion in pharmacology [Curr Opin Pharmacol] 2022 Jun; Vol. 64, pp. 102232. Date of Electronic Publication: 2022 May 05.

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 100966133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-4973 (Electronic) Linking ISSN: 14714892 NLM ISO Abbreviation: Curr Opin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Proteins ; United States

المؤلفون: Principe DR; Medical Scientist Training Program, University of Illinois College of Medicine, Chicago, IL 60612.; Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612.; Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60612., Aissa AF; Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60612., Kumar S; Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612., Pham TND; Department of Medicine, Feinberg School of Medicine, Northwestern University, Evanston, IL 60611., Underwood PW; Department of Surgery, University of Florida College of Medicine, Gainesville, FL 32611., Nair R; Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612., Ke R; Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612., Rana B; Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612., Trevino JG; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University, Richmond, VA 23284., Munshi HG; Department of Medicine, Feinberg School of Medicine, Northwestern University, Evanston, IL 60611.; Jesse Brown VA Medical Center, Chicago, IL 60612., Benevolenskaya EV; Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL 60612., Rana A; Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612.; Jesse Brown VA Medical Center, Chicago, IL 60612.

المصدر: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 May 03; Vol. 119 (18), pp. e2200143119. Date of Electronic Publication: 2022 Apr 27.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Pancreatic Neoplasms*/pathology, Amlodipine/pharmacology ; Amlodipine/therapeutic use ; Animals ; Calcium Channel Blockers/pharmacology ; Calcium Channel Blockers/therapeutic use ; Calmodulin ; Deoxycytidine/analogs & derivatives ; Humans ; United States ; Gemcitabine ; Pancreatic Neoplasms